Autres langues Algorae Pharmaceuticals Limited

Actions

1AI

AU0000296022

Recherche biotechnologique et médicale

Temps Différé Australian S.E. 04:21:16 13/10/2026			Varia. 5j.	Varia. 1 janv.
0,009000 ^AUD	+12,50%		0,00%	-35,71%

31/08	Algorae Pharmaceuticals Limited publie ses résultats pour l'exercice clos le 30 juin 2026	CI
15/07	Algorae Pharmaceuticals Limited annonce des changements au sein de son conseil d'administration, effectifs au 14 juillet 2026	CI

Autres langues

31/08	Algorae Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2026
15/07	Algorae Pharmaceuticals Limited Announces Board Changes, Effective July 14, 2026
02/07	Algorae Pharmaceuticals Limited Appointed as Supplier Under Nsw Health Public Hospital Supply Contract
30/06	Algorae Pharmaceuticals Limited Announces Appointment of Geraldine Holland and Catherine Earlie as Joint Company Secretaries, Effective July 1, 2026
06/05	Algorae Pharmaceuticals executes license & supply agreement with Torrent Pharma
28/04	Algorae pharmaceuticals and Zydus enter exclusive commercial agreement
02/04	Algorae Pharmaceuticals raises A$3.9 million at A$0.012 per share
02/04	Algorae Pharmaceuticals says TGA accepts initial registration dossier for evaluation
30/03	Algorae pharmaceuticals partners with Peter MacCallum Cancer Centre for second AI-driven drug synergy screening program
19/03	Algorae Pharmaceuticals Ltd Announces Appointment of Waleed Elsayed as Head of Sales
09/03	Algorae Pharmaceuticals Limited Announces Board Changes, Effective March 10, 2026
27/02	Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2025
08/02	Algorae Pharmaceuticals signs license & supply agreement with Cadila
21/01	Algorae Pharmaceuticals secures A$3 million debt facility with ScotPac
27/11	ASX Small-Cap Stocks to Watch
27/11	Algorae Pharmaceuticals signs distribution agreement with Dr. Reddy's Laboratories
20/10/25	Algorae Pharmaceuticals signs binding term sheet with Cadila Pharmaceuticals
23/09/25	Algorae Pharmaceuticals Enters Licensing Agreement with Indian Manufacturer for Launch of Generic Oncology Medicines in Australia, New Zealand
23/09/25	Algorae Pharmaceuticals signs exclusive license agreement with Sakar
28/08/25	Algorae Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2025
08/05/25	Algorae Pharmaceuticals Working With Victoria Cancer Center for Drug Synergy Screening
08/05/25	Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
03/04/25	Algorae Pharmaceuticals Limited Announces the Appointment of Vishal Shah as Chief Commercial Officer
26/02/25	Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2024
30/08/24	Algorae Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2024